| Record ID | ia:vasopressin0002unse |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/vasopressin0002unse/vasopressin0002unse_marc.xml |
| Download MARC binary | https://www.archive.org/download/vasopressin0002unse/vasopressin0002unse_meta.mrc |
LEADER: 01673cam 2200481 4500
001 ocm00700785
003 OCoLC
005 20221117054438.0
008 730814m19731974nyua b 001 0 eng
010 $a 73014544
040 $aDLC$beng$cDLC$dOCLCQ$dNLM$dBTCTA$dOCLCG$dOCLCO$dOCLCF$dOCLCQ$dOCLCO
016 7 $a0412740$2DNLM
020 $a0842271236$q(v. 1)
020 $a9780842271233$q(v. 1)
020 $a0842271279
020 $a9780842271271
035 $a(OCoLC)700785
050 00 $aRM291.7.V3$bV37
060 00 $aWK 520$bV334
082 00 $a612/.492
245 00 $aVasopressin;$cpapers by J.D. Glickson [and others].
260 $aNew York,$bMSS Information Corp.$c[1973-74]
300 $a2 volumes$billustrations$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
500 $aVol. 2 by C.A. Pissiotis and others.
504 $aIncludes bibliographical references.
505 0 $a1. Chemical and clinical aspects.--2. Clinical aspects.
650 0 $aVasopressin.
650 2 $aVasopressins
650 6 $aVasopressine.
650 7 $aVasopressin.$2fast$0(OCoLC)fst01164595
655 2 $aCollected Work
700 1 $aGlickson, Jerry D.,$d1941-
700 1 $aPissiotis, C. A.
776 08 $iOnline version:$tVasopressin.$dNew York, MSS Information Corp. [1973-74]$w(OCoLC)598678758
776 08 $iOnline version:$tVasopressin.$dNew York, MSS Information Corp. [1973-74]$w(OCoLC)607826592
938 $aBaker and Taylor$bBTCP$n73014544 //r912
029 1 $aAU@$b000000509680
029 1 $aNLM$b0412740
994 $aZ0$bGTX
948 $hNO HOLDINGS IN GTX - 47 OTHER HOLDINGS